SUDA Signs Agreement For SUD-001H For US Market
Filed with ASX · · 3 pages · English
Arovella Therapeutics Limited on 6ix
Earlier from Arovella Therapeutics
- Appendix 4C, Market Update and Top 20
- Request for Trading Halt
- SUDA Achieves TGA GMP Licence
- Business Development Update
- Anagrelide Update
Later from Arovella Therapeutics
- ZolpiMist Market Update
- SUDA Receives R&D Tax Incentive Refund
- SUDA Enters Agreement To Develop Cannabinoid Spray
- ZLD to Invest in Development of Oral Spray Formulations
- SUDA Signs Agreement With Mitsubishi Tanabe
Follow Arovella Therapeutics into a list and get an email when it puts out news.
Follow Arovella Therapeutics